Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
32.67
-4.40 (-11.87%)
At close: Nov 20, 2024, 4:00 PM
32.79
+0.12 (0.37%)
After-hours: Nov 20, 2024, 7:58 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $233.14 million as of November 21, 2024. Its market cap has increased by 1,209.76% in one year.
Market Cap
233.14M
Enterprise Value
228.73M
1-Year Change
1,209.76%
Ranking
Category
Stock Price
$32.67
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $233.14M, an increase of 457.98%. That is a compound annual growth rate of 57.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 233.14M | 3,153.56% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | 41.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Precigen | 245.04M |
| Pulmonx | 244.82M |
| TruBridge | 236.63M |
| Inventiva | 236.24M |
| LifeMD | 234.75M |
| Aurora Cannabis | 233.00M |
| ModivCare | 232.97M |
| Eledon Pharmaceuticals | 230.00M |